Valuation : AcouSort AB

Market Cap 63.28M 6.65M 5.71M 5.34M 4.89M 9.22M 635M 9.24M 24.74M 320M 24.97M 24.43M 1.06B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 63.28M 6.65M 5.71M 5.34M 4.89M 9.22M 635M 9.24M 24.74M 320M 24.97M 24.43M 1.06B EV / Sales 2026 *
6.39x
EV / Sales 2027 * 4.28x
Free-Float
70.68%
Yield 2026 *
-
Yield 2027 * -
1 day+3.34%
Current month-12.46%
1 month-13.69%
3 months-29.61%
6 months+27.16%
Current year+9.19%
1 week 2.5
Extreme 2.5
3.49
1 month 2.5
Extreme 2.5
3.7
Current year 2.03
Extreme 2.03
5.16
1 year 2.03
Extreme 2.03
5.16
3 years 2.03
Extreme 2.03
28.6
5 years 2.03
Extreme 2.03
32.95
10 years 2.03
Extreme 2.03
32.95
Manager TitleAgeSince
Chief Executive Officer 68 01/01/2014
Director of Finance/CFO 65 01/01/2016
Director TitleAgeSince
Director/Board Member 64 01/01/2012
Chairman 65 01/01/2011
Director/Board Member - 01/12/2021
Change 5-day change 1-year change 3-year change Capi.($)
+3.34%0.00%-10.17%-82.83% 6.65M
-0.24%-0.95%+2.98%+23.36% 51.14B
+2.65%+4.45%+481.36%+567.32% 47.4B
+0.33%+2.47%+38.97%+19.80% 43.19B
-0.88%+0.90%+24.11%+87.74% 42.35B
-2.27%-3.02%+14.22%+51.50% 33.23B
-1.21%-0.17%+29.16%+135.38% 17.07B
-0.36%-2.14% - - 16.38B
-0.47%-0.25%+12.06%+28.28% 14.76B
+0.44%+1.70%+82.07%+47.92% 14.15B
Average +0.13%+0.06%+74.97%+97.61% 27.97B
Weighted average by Cap. -0.05%+1.04%+106.28%+143.47%

Financials

2026 *2027 *
Net sales 9.9M 1.04M 893K 836K 766K 1.44M 99.36M 1.45M 3.87M 50.08M 3.91M 3.82M 166M 14.8M 1.56M 1.33M 1.25M 1.14M 2.16M 149M 2.16M 5.79M 74.86M 5.84M 5.71M 248M
Net income - -
Net Debt - -
Logo AcouSort AB
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Employees
11
Date Price Change Volume
28/08/26 SEK 3.090 +3.34% 1,280
27/08/26 SEK 2.990 0.00% 30,203
26/08/26 SEK 2.990 +7.94% 35,749
25/08/26 SEK 2.770 -7.05% 114,370
24/08/26 SEK 2.980 -2.61% 54,640

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACOU Stock